School of Medicine
Showing 1-34 of 34 Results
-
Blake K. Scanlon, Ph.D.
Adjunct Lecturer, Psych/Public Mental Health & Population Sciences
BioThe overarching aim of Dr. Scanlon’s research is to develop and evaluate low-cost, pragmatic and clinically translatable methods for improving management of neurodegenerative disease and dementia. To that end, the Caregiver Technology Division of the Scanlon Lab aims to enhance patient- and family-centered care through novel, broadly customizable, and highly scalable caregiver interventions. In parallel, the Neurodegenerative Division of the Scanlon Lab focuses on the development and application of cognitive, neuropsychiatric, and biological markers for the initiation and progression of neurodegeneration.
Dr. Scanlon received his bachelor’s degree in Neuroscience and doctorate in Clinical Health Psychology from the University of Miami. After concluding his clinical internship in Geropsychology/Neuropsychology at the VA Palo Alto Health Care System (VAPAHCS), he completed fellowships in Aging and Dementia at Stanford University School of Medicine and VAPAHCS. Dr. Scanlon is currently a VA Career Development Awardee in the Sierra-Pacific Mental Illness Research, Education, and Clinical Center (MIRECC) and Stanford/VA Aging Clinical Research Center where his work focuses on developing and evaluating low-cost, pragmatic and clinically translatable methods for improving management of neurodegenerative disease and dementia. He also serves as Co-Director of the Stanford/VA California Alzheimer's Disease Center, Chair of the VAPAHCS Dementia Committee, and Co-Chair of the Department of Veterans Affairs VISN 21 Dementia Committee. -
Jacqueline Erin Shanley
Casual - Non Exempt, Psych/General Psychiatry and Psychology (Adult)
BioJacqueline is a psychology doctoral student in the PGSP-Stanford PsyD Consortium Program. She has multiple years of experience working in healthcare settings; she has both worked with patients who have autoimmune conditions and varying forms of dementia, alongside their families. Her research and clinical interests include health psychology, women's health, and relationships science.
-
G. Dave Singh DMD PhD DDSc
Adjunct Professor, Psychiatry and Behavioral Sciences - Sleep Medicine
BioDr Dave Singh is a US citizen who was born, educated and trained in England, UK. He holds three doctorates, including Doctor of Dental Medicine; a Ph.D. in craniofacial cleft palate development; and a third Doctorate in Orthodontics. Currently, Dr Singh is an Adjunct Professor in Sleep Medicine at Stanford University, USA. Previously, he was awarded a postgraduate grant (University of Oxford, UK) and was later appointed to the Board of Examiners, Royal College of Surgeons of England. Supported by Harvard University, the University of Michigan, and the University of Hawaii, he was invited to relocate to the Center for Craniofacial Disorders, University of Puerto Rico, USA where he led a NIH-funded program of clinical craniofacial research. He is an honorary diplomate of the American Sleep and Breathing Academy, a Member of the World Sleep Society, a Member of the American Academy of Sleep Medicine, a Member of the World Dentofacial Sleep Society, a Member of the NC Academy of Sleep Medicine, a Fellow of the Pierre Fauchard Academy, an Academic Fellow of the World Federation of Orthodontists, and a Fellow of the International Association for Orthodontics, where he was awarded prizes in 2005, 2013 and 2014. He has published over 220 articles in the peer-reviewed medical, dental and orthodontic literature, has published 9 books/chapters and has had over 20 US, Canadian, European and international patents issued. During 2008-2016, Dr Singh was the Founder and CEO of his start-up company, which was successfully listed on NASDAQ after its IPO in 2020. In 2019, Dr. Singh was the recipient of the US Invisible Disabilities Association award. In 2020, Dr Singh was given a lifetime achievement award for his work on obstructive sleep apnea. Dr Singh is the inventor of the DNA appliance, which was the first palatal expander to be FDA approved in 2023 for the treatment of mild-moderate as well as severe obstructive sleep apnea in adults. In 2024, the DNA appliance became the first palatal expander to be FDA approved for the treatment of obstructive sleep apnea in children
-
David Smith, M.D.
Adjunct Professor, Psych/General Psychiatry and Psychology (Adult)
BioDr. Smith is a psychiatrist and clinical psychopharmacologist in private practice in Palo Alto, CA, and an Adjunct Professor in the Department of Psychiatry & Behavioral Sciences at Stanford University School of Medicine. He majored in both biological science and English literature at Cornell University, received his M.D. from UCLA, and completed his psychiatry residency and NIMH research fellowship at Stanford University School of Medicine and Hospital.
-
Ana Lilia Soto
Youth Development Manager, Psych/Public Mental Health & Population Sciences
Current Role at StanfordYouth Development Manager
-
Aline Rocha
INSPIRE Training Manager, Psych/Public Mental Health & Population Sciences
Current Role at StanfordINSPIRE Training Manager
-
Caleb Matthew Spiro
Casual Non-Exempt, Psychiatry and Behavioral Sciences
BioMy main research interest revolves around understanding the general cognitive and affective properties of the mind, and how the prognosis of good and poor mental health status affects the developmental trajectories under chronic stress. To what extent reward-based networks can lead to increased proximity to vulnerability or heightened sensitivity to mental illness, specifically within the context of youth and adolescents, is an area that I am especially interested in. I am most interested in what factors help individuals become more resilient and build a narrative that they can get better with the right treatment practices. I believe that this can be done by combining neuroscience and functional imaging techniques (ex: fMRI, EEG) into the study and practice of clinical psychology.
